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Abstract
Background: Family physicians can play an important role in encouraging patients to participate in community-based
health promotion initiatives designed to supplement and enhance their in-office care. Our objectives were to determine
effective approaches to invite older family practice patients to attend cardiovascular health awareness sessions in
community pharmacies, and to assess the feasibility and acceptability of a program incorporating invitation by physicians
and feedback to physicians.
Methods: We conducted a prospective randomized trial with 1 family physician practice and 5 community pharmacies
in Dundas, Ontario. Regular patients 65 years or older (n = 235) were randomly allocated to invitation by mail or
telephone to attend pharmacy cardiovascular health awareness sessions led by volunteer peer health educators. A health
record review captured blood pressure status, monitoring and control. At the sessions, volunteers helped patients to
measure blood pressure using in-store machines and a validated portable device (BPM-100), and recorded blood
pressure readings and self-reported cardiovascular risk factors. We compared attendance rates in the mail and telephone
invitation groups and explored factors potentially associated with attendance.
Results: The 119 patients invited by mail and 116 patients contacted by telephone had a mean age of 75.7 (SD, 6.4) years
and 46.8% were male. Overall, 58.3% (137/235) of invitees attended a pharmacy cardiovascular health awareness session.
Patients invited by telephone were more likely to attend than those invited by mail (72.3% vs. 44.0%, OR 3.3; 95%CI 1.9–
5.7; p < 0.001).
Conclusion: While the attendance in response to a telephone invitation was higher, response to a single letter was
substantial. Attendance rates indicated considerable interest in community-based cardiovascular health promotion
activities. A large-scale trial of a pharmacy cardiovascular health awareness program for older primary care patients is
feasible.
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Background
Hypertension is a major contributor to cardiovascular dis-
ease and associated morbidity and mortality among older
adults in Canada. The prevalence of hypertension
increases with age and more than half of men and women
65 to 74 years of age have a systolic or diastolic blood
pressure above the target level of 140/90 mmHg (or 130/
80 mmHg if diabetes or target organ damage is present)
recommended by the Canadian guidelines [1,2]. High
blood pressure is an important and modifiable risk factor
for heart disease, stroke, renal failure, peripheral vascular
disease [3], and Alzheimer's disease [4]. Since elevated
blood pressure is generally asymptomatic, it is important
to find effective strategies to facilitate diagnosis and con-
trol of hypertension and promotion of the cardiovascular
health in communities across Canada.
The diagnosis of hypertension is primarily made in the
offices of family physicians [3]. Although provincial sur-
vey data indicate that nearly all older adults in Ontario
visit their physician annually [5], there is evidence that
one half to one third of patients have elevated blood pres-
sures for which no diagnosis is recorded or treatment pre-
scribed [6].
Effective diagnosis and control of hypertension depends
on physicians' awareness of a patient's blood pressure sta-
tus and cardiovascular risk profile over time [7]. Diagnos-
ing hypertension can be complicated and frequently
requires multiple assessments over time [8]. In-office
monitoring may be limited by infrequent patient visits,
co-morbid conditions, time or space constraints, remu-
neration and the presence of 'white coat', or 'masked'
hypertension.
Since multiple, accurate blood pressure readings are
needed to diagnose hypertension and regular monitoring
is necessary for effective, on-going control of high blood
pressure, accurate supplementary readings, a cardiovascu-
lar health profile, and more active involvement of patients
in their care may help physicians to better manage hyper-
tension in their practices. Blood pressure monitoring in a
familiar, convenient community setting such as commu-
nity pharmacies, with support from trained peer volun-
teers and delivery of patient-specific blood pressure
readings and cardiovascular risk factor information to
family physicians, pharmacists and the patients, could
help overcome barriers to effective management [9].
Family physicians can play an important role in encourag-
ing patients to participate in health promotion initiatives
designed to supplement and enhance their in-office care.
In a study by McAuley et al, a letter of invitation from the
family physician was found to be an effective strategy to
recruit women for routine mammography, with nearly
70% success [10]. Given that public opinion polls demon-
strate that physicians are among the most trusted profes-
sionals [11], patient acceptance of new approaches to
routine care may be largely dependent on their physician's
endorsement and involvement. Older patients with a long
relationship with their family physician may be particu-
larly receptive to the physician's advice. A recent study
recruiting older adults in family practice achieved a 70%
success rate and found that the median time of patient
association with the current physician was 10.2 years in
the intervention group and 11.5 years in the control
group, with a standard deviation of 9 years [12].
The program described here seeks to: 1) maximize use of
existing resources such as community pharmacies and
volunteers in cardiovascular health promotion; 2) ensure
that community-based cardiovascular risk assessment is
linked to family physicians who can provide follow up.
The program is unique because it incorporates collection
of patient-reported risk factors in addition to blood pres-
sure readings, and 'closes the loop' by delivering results to
the physician. However, there are many community pro-
grams offering blood pressure monitoring, and the idea of
inviting older adults via family practices to attend a new
program for cardiovascular health assessment prompted
some scepticism – would they come? A first step was to
determine the effectiveness of different approaches for
inviting older adults to participate in pharmacy cardiovas-
cular health awareness sessions, and the appeal of a pro-
gram incorporating invitation by physicians and feedback
of patient-specific results to physicians.
We conducted a randomized trial to determine the best
method (mail or telephone) for family physicians' offices
to invite patients to attend a session, and to identify fac-
tors that predicted attendance. In preparation for a larger
scale randomized controlled trial, we also performed a
cost analysis of invitation method and success rate, inves-
tigated the operational and methodological aspects of the
proposed intervention, and queried patients' willingness
to continue to attend community pharmacy blood pres-
sure sessions and their preferences for the time and fre-
quency of the sessions.
Methods
The study design was a prospective randomized trial (see
Figure 1). The primary end-point was the overall attend-
ance among patients invited by mail compared to those
invited by telephone. Potential predictors of attendance,
including cardiovascular risk factors recorded in patient
health records, were assessed. The study was approved by
the Hamilton Health Sciences / McMaster University Fac-
ulty of Health Sciences Research Ethics Board.BMC Family Practice 2005, 6:35 http://www.biomedcentral.com/1471-2296/6/35
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Eligible patients were identified from the practice roster of
one family physician. Patients were eligible to participate
if they were 65 years of age or older, considered by the
physician to be regular patients, community dwelling,
and able to attend a cardiovascular health promotion ses-
sion in a local pharmacy. Patients were excluded if they
suffered from dementia or a serious, non-cardiovascular
disease or condition, or were non-English speaking and
could not attend with an English-speaking companion.
An electronic list of patients 65 years or older (n = 490)
was generated using billing data. Of these, 235 met the eli-
gibility criteria and were included in the trial. The list was
reviewed and eligibility verified by the physician. The tar-
geting of regular patients reflects the increasing move to
Study design and patient flow Figure 1
Study design and patient flow.
Electronic roster of patients 65 years of age or older
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rostered practices in Ontario and the potential impor-
tance of an established relationship with the provider,
where mail/telephone contact related to health promo-
tion would not be unusual.
Computer-generated random numbers were used to allo-
cate eligible patients to invitation by mail (n = 119) or by
telephone (n = 116) to attend one of five blood pressure
monitoring sessions scheduled in five local pharmacies.
To prevent potential contamination of the study arms,
patients sharing the same address and/or surname were
assigned identical identification numbers and thus ran-
domly allocated to the same group. Mailed letters used an
electronic signature from the physician. Patients assigned
to the telephone group received a telephone call from a
member of the physician's office staff who followed a pro-
tocol that limited repeat calls to three and included a
structured script. Patients who were unreachable by either
contact method (letters returned to sender or calls busy/
unanswered) were included in the intention-to-treat anal-
ysis of attendance by invitation method in order to estab-
lish the feasibility of the program in real practice.
Research nurses performed a baseline health record
review to confirm patient eligibility, collect demographic
and health status factors that might influence session
attendance, and document blood pressure monitoring
and control. Data collected included age, gender, formal
diagnosis or suspicion of hypertension, related physician
comments, cardiovascular risk factors (diabetes, high cho-
lesterol, smoking, family history), and all blood pressure
readings recorded in the chart in the previous six months.
The five pharmacy blood pressure sessions were held dur-
ing a 10-day period in April of 2001. Attending patients
were asked to provide signed informed consent to partici-
pate. Patients were able to 'opt-out' of the feedback to the
physician, however no participants in this small trial
objected to having their results forwarded to the physi-
cian. At the sessions, volunteer Peer Health Educators
trained by a public health nurse helped participants to
measure their blood pressure using both a portable, auto-
mated device (BPM-100, VSM MedTech Ltd., Coquitlam,
Canada) [13] and the in-store device, and recorded results
and additional patient-reported cardiovascular risk fac-
tors. The portable device had been validated and met
international standards for accuracy [13,14].
The session recording form captured, in triplicate, blood
pressure readings and a checklist of 14 cardiovascular risk
factors for distribution to the patient, family physician
and regular pharmacist. A patient questionnaire collected
demographic and general health information, current
blood pressure status and history, history of related health
problems, and preferences for place, time and frequency
of blood pressure monitoring.
Statistical analysis
To achieve a power of 80% to detect a difference between
groups of 20% or more, the significance level (alpha) was
set at 0.05 and at least 103 patients were required for each
study arm. The comparability of groups was established
maintaining the denominator of all patients randomized
(n = 235), regardless of whether or not telephone or mail
contact was successful. The probability of a Type I error
(alpha) was chosen to be 0.05 (two-tailed) in all analyses.
Patients allocated to the mail or telephone contact group
were compared on data collected in the health record
review: median age, gender, mean blood pressure, level of
blood pressure, previous diagnosis of hypertension,
smoking status, family history of cardiovascular disease,
high cholesterol, and diabetes. The mean of the blood
pressure readings recorded in the last six months, col-
lected in the health record review, were categorized in
three levels, based on whether the systolic or diastolic
pressure exceeded upper boundaries.
To determine whether attending patients systematically
responded differently to the invitation method, attenders
and non-attenders were compared on median age, gender,
mean blood pressure, and previous diagnosis of hyperten-
sion using t-tests or chi-square tests as appropriate. We
examined the potential association of factors captured in
the health record review (formal diagnosis or suspicion of
hypertension, related physician comments, cardiovascu-
lar risk factors, blood pressure control) with attendance at
the cardiovascular health promotion sessions, using chi-
square tests.
To determine what combination of variables best pre-
dicted the likelihood of patient attendance at community-
based cardiovascular health promotion sessions, logistic
regression was performed, controlling for allocation
group. Variables entered into the stepwise model included
contact method, age (65–74 yr or 75+), gender, diagnosis
of hypertension, and the four cardiovascular risk factors
(diabetes, high cholesterol, smoking, family history) col-
lected in the health record review.
A retrospective cost-analysis compared the cost per one
patient attending in each invitation arm.
Results
Patients allocated to each of the experimental groups
(mail and telephone invitation) were found to be compa-
rable on median age, gender, mean blood pressure, level
of blood pressure, previous diagnosis of hypertension,
and four additional cardiovascular risk factors (see TableBMC Family Practice 2005, 6:35 http://www.biomedcentral.com/1471-2296/6/35
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Table 1: Characteristics of 235 patients randomly allocated to mail or telephone invitation to attend a cardiovascular health 
promotion session.




Median Age (min 65 – max 96) Male 76 77
Female 76 75
Gender Male 55 (47.4) 55 (46.2)
Mean blood pressure in health record (mm Hg)* 136 / 71 136 / 72
Formal diagnosis of hypertension* 50 (44.2) 56 (50.0)
Health record blood pressure readings (mm Hg)* ≤ 140 and ≤90 62 (54.4) 65 (57.5)
≥140 or ≥90 to ≤160 and ≤100 38 (33.3) 36 (31.9)
≥160 or ≥100 or no readings 14 (12.3) 12 (10.6)
Cardiovascular risk factors* Smoking 47 (41.2) 37 (32.7)
Family history 33 (29.2) 36 (31.9)
High cholesterol 40 (35.4) 45 (39.8)
Diabetes 17 (15.0) 22 (19.5)
* During the health record review, 8 patients were discovered to be ineligible and 1 audit was incomplete. Therefore, the denominator for health 
record review data ranges from 112 to 114.
Table 2: Characteristics of the 98 non-attending patients compared to 137 patients who attended a cardiovascular health promotion 
session.
Patient Characteristics Non-attenders n = 98(%) Attenders n = 137(%)
Median Age (yr; 65–96) Male 76 75
Female 76 77
Gender Male 45 (45.9) 65 (47.4)
Mean blood pressure in health record (mm Hg) 135 / 71 137 / 72
Formal diagnosis of hypertension* 46 (51.7) 60 / 136 (44.1)
Family physician-reported cardiovascular risk factors* Smoking 34 (38.2) 50 (36.5)
Family history† 20 (22.5) 49 (35.8)
High cholesterol 37 (41.6) 48 (35.0)
Diabetes 14 (15.7) 25 (18.2)
* During the health record review, 8 patients were discovered to be ineligible and 1 audit was incomplete. Therefore the denominator for health 
record review data is 89 for the non-attenders and 136-7 for attenders
† p < 0.05BMC Family Practice 2005, 6:35 http://www.biomedcentral.com/1471-2296/6/35
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1). Patients who attended a session and those who did not
were also found to be comparable on median age, gender,
previous diagnosis of hypertension, and four additional
cardiovascular risk factors (see Table 2).
In the mail contact group, 8 letters were returned to
sender. In the telephone contact group, all patients were
reached in three tries or called back, and 4 were discovered
to be ineligible on contact.
Overall, 58.3% (137/235) of invited patients attended a
session. In the group invited by mail, 44.0% (51/116)
patients attended, compared to 72.3% (86/119) among
those invited by telephone. In univariate analyses,
patients invited by telephone were significantly more
likely to attend than were those invited by mail (OR 3.3;
95%CI 1.9–5.7; p < 0.001), and patients with a family his-
tory of cardiovascular disease noted in their chart were
also significantly more likely to attend (OR 1.9; 95%CI
1.1–3.5;  p  = 0.049). In multivariate logistic regression
modelling (n = 226), factors remaining significantly asso-
ciated with attendance were invitation method (tele-
phone) (OR 3.9, 95%CI 2.2–7.0; p < 0.001) and family
history of cardiovascular disease recorded in the health
record (OR 2.0, 95%CI 1.0–3.7; p = 0.38) (see Table 3).
Of the patients who attended a session and completed the
questionnaire (n = 130), 80.0% (95/119) indicated an
interest in attending again and 70.2% (85/121) preferred
a session in the morning. The preference expressed for dif-
ferent invitation methods was close to evenly divided
(49.6% mail and 50.4% telephone) and there was a ten-
dency for patients to state a preference for the type of invi-
tation they had actually received, mail (72.1%; 31/43) or
telephone (64.3%; 45/70), with more patients contacted
by telephone attending.
Mailing costs included postage ($0.47 × 116 patients =
$54.52), stationary/printing ($8.50) and research assist-
ant time to prepare the letters and correct addressing prob-
lems (4 hrs × $12/hr = $48.00). The telephone cost was
for research assistant time to prepare a patient list and call-
ing log (2 hrs × $12/hr = $24.00), and practice staff time
(6 hrs at $25/hr = $150.00). Since 51 patients invited by
mail attended, the cost per successful recruitment of one
patient was $111.02 / 51 = $2.18. Of patients invited by
Table 3: Univariate and multivariate analyses to detect an association between specific variables and attendance at a session.




Invitation Method Mail 51 (44.0) 1.0† 1.0†
Telephone 86 (72.3) 3.3 (1.9–5.7) ‡ 3.9 (2.2–7.0) ‡
Age (min 65 – max 96 yrs) 65–74 58 (58.0) 1.0†
75+ 79 (58.5) 1.0 (0.6–1.7)
Gender Female 72 (59.6) 1.0†
Male 65 (59.0) 1.1 (0.6–1.8)
Diagnosis of Hypertension§ No 76 (63.9) 1.0†
Yes 60 (56.6) 0.7 (0.4–1.3)
Family physician-reported cardiovascular risk factors|| Smoking 87 (61.3) 1.0†
50 (59.5) 0.9 (0.5–1.6)
Family history 88 (56.1) 1.0† 1.0†
49 (71.0) 1.9 (1.0–3.5) ‡ 2.0 (1.0–3.7) ‡
High cholesterol 89 (63.1) 1.0†
48 (56.5) 0.8 (0.4–1.3)
Diabetes 112 (59.9) 1.0†
25 (64.1) 1.2 (0.6–2.4)
* model based on 226 cases with data from health record review
† reference category
‡ p < 0.05
§ based on 225 cases with data from health record review
|| based on 226 cases with data from health record reviewBMC Family Practice 2005, 6:35 http://www.biomedcentral.com/1471-2296/6/35
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telephone, 86 attended, for a per-patient cost of $174.00
/ 86 = $2.02, indicating a minimal difference in efficiency.
Discussion
The pharmacy sessions were well attended, indicating that
organized community-based blood pressure monitoring
with feedback to the family physician is feasible, and
could enhance the diagnosis and management of hyper-
tension by increasing the number of accurate readings
available to the physician, and raising awareness among
older adults of cardiovascular risk factors. The pilot dem-
onstrated the advantage of incorporating invitation by tel-
ephone rather than mail, however the attendance rates for
both groups and preferences reported by attendees dem-
onstrated the success and acceptance of either method.
Although attendance was higher in the telephone group,
results also support use of mailed invitations, which are
more easily implemented on a larger scale. The cost anal-
ysis demonstrated a minimal difference, and patient pref-
erence among attenders reflected the acceptability of
either invitation method.
These findings are in keeping with similar studies of
reminder strategies for preventive services in family prac-
tice. One study found an equal procedure completion rate
among patients 15 years of age or older (n = 5883) of five
preventive procedures with use of letter and telephone
reminders, which was higher than that achieved through
computerized physician reminders [15]. Procedure com-
pletion rates in both the letter and telephone groups were
42.0%, and letters were found to be more cost-effective.
Attendance at the Dundas sessions was higher, at 58.3%
of invited patients on average, than might be expected
from a single contact, particularly since participation
involved attending one of a limited number of sessions
held on specific days at five community pharmacies. The
excellent attendance in response to a single letter or tele-
phone call from the physician's office demonstrates that
engaging older adults to participate in community-based
initiatives, in cooperation with family physicians, is an
effective and low-cost approach to cardiovascular health
promotion.
Only two factors (invitation method and family history of
cardiovascular disease) entered into the logistic regression
model accounted for a significant portion of the variance
in attendance, however these results are reassuring in the
context of this population-health program. It was
expected that male patients or very elderly patients might
be less likely to attend community-based blood pressure
monitoring, however, logistic regression analysis reveals
that the program achieved good coverage of all patients,
across the key variables of age, gender, hypertensive sta-
tus, and cardiovascular risk factors.
A number of limitations of this pilot could be remedied in
a larger study. For instance, the results of this study in one
family physician's practice may not be generalizable to
other practices, the success of one nurse in inviting
patients may not be representative, and the limited time
period in which the sessions were offered may have pre-
cluded attendance by some patients.
Conclusion
While the attendance in response to a telephone invita-
tion was higher, response to a single letter was substantial.
Contact by the family physicians office was effective in
encouraging older patients to participate in community-
based assessment of cardiovascular risk factors, with feed-
back of results to the family physician. The pilot provided
important perspectives toward expanding the program to
a larger number of family physician practices, pharmacies,
and older adults.
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